Medical Properties Trust, Inc.

Medical Properties Trust, Inc. (MPW) Market Cap

Medical Properties Trust, Inc. has a market capitalization of $3.22B.

Price: $5.36

0.08 (1.52%)

Market Cap: 3.22B

NYSE · time unavailable

CEO: Edward K. Aldag Jr.

Sector: Real Estate

Industry: REIT - Healthcare Facilities

IPO Date: 2005-07-08

Website: https://www.medicalpropertiestrust.com

Medical Properties Trust, Inc. (MPW) - Company Information

Market Cap: 3.22B|Sector: Real Estate

Company Profile

Medical Properties Trust, Inc. (MPW) is a self-managed real estate investment trust (REIT) established in 2003. Its core business involves acquiring and developing hospital properties that are then leased back to operators on a net basis. Originating in Birmingham, Alabama, the company has expanded significantly to become one of the foremost global owners of hospital real estate. As of September 30, 2023, its portfolio encompassed 441 facilities and approximately 44,000 licensed beds. More recently, subsequent to the third quarter's close, MPT divested four facilities. Consequently, its current holdings span roughly 43,000 licensed beds across nine countries and three continents. The MPT financing framework offers a strategic advantage, facilitating both property acquisitions and recapitalizations. This model empowers hospital operators to unlock the inherent value in their real estate, channeling these funds into crucial areas like facility modernizations, technological advancements, and other operational investments.

Analyst Sentiment

56%
Buy

From 8 Active Polls

1Y Forecast: $11.54

▲ +115.3% Potential Upside

Consensus Target Metrics

Low Bound

$5

Median

$8

High Bound

$27

Average

$12

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$11.54
▲ +115.30% Upside
Low Target
$5.00
-7% Risk
Median Target
$8.00
49% Mid
High Target
$27.00
404% Max
Consensus
Hold
11 / 28 Buys

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

📊 Historical Valuation Multiples

Real-time Trailing Twelve Month (TTM) momentum side-by-side with discrete quarterly metrics.

Fiscal QuarterTTMQ1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
Period EndingTrailing 12MMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024
Market Cap ($M)3,2242,7673,0053,0462,5893,6222,3723,5112,454
Enterprise Value ($M)12,10912,10812,29012,41511,87812,56311,01612,58811,377
Price to Earnings Ratio (P/E)-22.3121.3644.17-9.75-6.73-7.54-1.43-1.09-1.89
Price/Earnings-to-Growth Ratio (PEG)3.20-0.91-0.34
Price to Sales Ratio (P/S)2.7710.9811.1112.8310.7716.1810.0815.559.21
Price to Book Ratio (P/B)0.610.610.650.650.540.760.490.650.40
Price to Free Cash Flow Ratio (P/FCF)12.81-194.0818.77164.0350.039431.2030.9359.3269.61
Enterprise Value to Sales (EV/Sales)48.0345.4652.2749.4256.1446.8355.7442.68
Enterprise Value to EBITDA (EV/EBITDA)12.7958.5024.8391.76108.29172.9262.15-26.27-113.98
Debt to Equity Ratio9.862.152.132.102.032.021.861.721.54

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 MEDICAL PROPERTIES TRUST REIT INC (MPW) — Investment Overview

🧩 Business Model Overview

Medical Properties Trust (MPW) operates as a healthcare-focused real estate owner and landlord. The company originates, acquires, and manages income-producing healthcare properties, then monetizes those assets primarily through long-duration leases to operating partners (healthcare providers). The economic structure is designed to pass through or share operating costs, creating a stabilized cash-flow profile that is typical of net-lease real estate.

From a value-chain perspective, MPW’s model depends on (1) identifying real estate that aligns with healthcare operating demand, (2) underwriting tenant credit and reimbursement sensitivity, and (3) managing property performance and lease administration through cycles in healthcare utilization. The practical “stickiness” stems from location specificity, clinical and operational fit, and the friction involved in relocating an established healthcare service line.

💰 Revenue Streams & Monetisation Model

MPW monetizes properties largely through contractual rent payments under lease agreements. Revenue is predominantly recurring in nature because healthcare real estate is typically leased on long terms. Cash flows are influenced by lease structure, including fixed-rent components, escalation terms, and the extent to which reimbursements or operating metrics at the tenant level affect rent.

Margin drivers are primarily property-level and lease-level: (1) lease duration and rent escalators, (2) the credit quality of tenants and their ability to sustain operations, (3) the degree of cost pass-through versus MPW bearing operating expense, and (4) capital intensity required to keep facilities compliant and competitive for healthcare delivery standards.

🧠 Competitive Advantages & Market Positioning

MPW’s competitive position is anchored less in “brand” and more in operational specialization: healthcare real estate underwriting, structuring, and lifecycle management.

  • Switching costs / location specificity: Healthcare delivery models are typically dependent on site, fixed infrastructure, and regulatory and operational requirements. Once services are established in a facility, moving is costly and disruptive for providers.
  • Integrated ecosystem at the property level: MPW’s expertise in building or acquiring facilities that match provider operational needs (layout, patient flow, compliance requirements, and payer mix sensitivity) supports tenant retention and renewal outcomes.
  • Capital-markets and underwriting capability: Healthcare real estate is complex to finance and underwrite due to tenant reimbursement dynamics and regulatory exposure. MPW’s ability to structure leases and evaluate operator risk can create an execution advantage over less-specialized owners.

Competitive benchmarking (healthcare REITs):

  • Ventas (VTR): More concentrated in medical office and senior-related real estate exposure.
  • Welltower (WELL): Heavier weight in senior housing and post-acute operating ecosystems.
  • Omega Healthcare Investors (OHI): Focused on skilled nursing and related senior care facilities.

Contrast: While Ventas, Welltower, and Omega are positioned around specific healthcare sub-sectors (medical offices and/or senior/post-acute), MPW’s portfolio approach emphasizes healthcare facility real estate backed by leases to operating partners, with underwriting that reflects hospital and specialty-provider reimbursement and utilization dynamics.

🚀 Multi-Year Growth Drivers

  • Healthcare demand tailwinds: Aging demographics and persistent demand for inpatient and outpatient capacity support long-run real estate need in healthcare.
  • Facility modernization and replacement cycles: Regulatory compliance and clinical requirements create steady demand for redevelopments and upgrades, supporting property repositioning opportunities.
  • Outsourcing of real estate capital: Providers often prefer to access capital through sale-leaseback, structured leasing, or third-party ownership to free balance-sheet capacity—expanding the addressable pool of healthcare facilities suitable for REIT structures.
  • Lease structure as a compounding mechanism: Where lease terms include escalators and durable occupancy assumptions, cash flows can compound over time, subject to tenant performance and refinancing conditions.

Over a 5–10 year horizon, the TAM is driven less by “new buildings” and more by ongoing healthcare capital deployment, the need for operationally compatible facilities, and the ongoing reliance of providers on external real estate partners.

⚠ Risk Factors to Monitor

  • Tenant credit and lease performance risk: Healthcare operators can face reimbursement pressure and cost inflation. Weak operator performance can translate into rent shortfalls, lease modifications, or heightened restructuring risk.
  • Regulatory and reimbursement risk: Changes in Medicare/Medicaid and broader healthcare payment models can affect tenant cash flows and occupancy, impacting contractual economics and renewal negotiations.
  • Refinancing and interest-rate risk: Like other levered real estate companies, MPW’s equity outcomes can be sensitive to the cost and availability of capital during refinancing events.
  • Capital intensity and compliance costs: Healthcare facilities require continued investment to meet evolving standards; underinvestment can impair tenant attractiveness and long-run property value.
  • Concentration risk: Exposure to particular tenant types, geographies, or operating models can increase correlated outcomes during systemic downturns in provider economics.

📊 Valuation & Market View

Healthcare REIT valuation often reflects a blend of (1) NAV-informed frameworks (real estate value less liabilities), (2) income-based measures such as AFFO/FFO (quality and durability of cash flows), and (3) lease-by-lease risk assessment (tenant credit, lease duration, and rent escalations).

Key valuation sensitivities include: the durability of tenant cash flow, the perceived collectability of rent, the weighted-average lease term and renewal probability, property-level capex needs, and the cost of debt. In this sector, changes in expected tenant performance and refinancing conditions can move valuation more than broad market multiples alone.

🔍 Investment Takeaway

MPW offers a healthcare-real-estate platform with potential durability driven by real asset specificity and lease structures tied to operating partners. The moat is primarily structural—location and operational fit create friction to switching, while specialized underwriting and property lifecycle management support tenant retention. The investment case depends on disciplined risk management of tenant credit and reimbursement exposure, along with maintaining access to capital at acceptable rates to fund ongoing compliance and modernization.


⚠ AI-generated — informational only. Validate using filings before investing.

📰 Market News & Coverage

15 Stories Available

Real-time institutional reporting and market updates for MPW.

seekingalpha.com2026-07-12

My 4 Worst REIT Picks: Lessons Learned The Hard Way

I revisit four of my worst REIT picks—ARCP, MPW, SAFE, and IIPR—to extract hard-earned lessons and strengthen my investment process. ARCP's collapse highlighted that broken trust and poor management culture override apparent value and yield, making a swift exit essential when the thesis changes. MPW and IIPR exposed the dangers of chasing yield amid tenant fragility, leverage, and unreliable cash flows, while SAFE revealed the underestimated risk of duration in a rising-rate environment.

seekingalpha.com2026-05-21

Medical Properties Trust: The Comeback Setup Is Finally Lining Up

Medical Properties Trust (MPW) is trading at 68% of book value, with a 7% dividend yield fully covered by NFFO. MPW's $1.12 billion in contractual base rent is already on the books, with 85.9% locked in past 2035, supporting income durability. Recent real estate sales and financings validate MPW's asset base, countering the narrative that it overpaid for hospital properties.

247wallst.com2026-05-06

A $500,000 REIT Portfolio That Pays You Rent Without Owning a Single Property

A $500,000 rental property can generate meaningful monthly cash flow, but the net amount depends heavily on rent, financing, taxes, insurance, repairs, vacancies, and management costs. A $500,000 REIT basket offers a different version of real estate income: publicly traded shares, professional management, daily liquidity, and no direct landlord duties. The tradeoff is that the... A $500,000 REIT Portfolio That Pays You Rent Without Owning a Single Property

seekingalpha.com2026-04-28

Medical Properties Trust: From Crisis To Comeback

Medical Properties Trust (MPW) remains a 'strong buy' as operational recovery accelerates and tenant issues are largely resolved. MPW's re-tenanting efforts and new leases are driving rent growth, with annualized cash rent targeted at $1 billion by year-end. Despite high net leverage (9x), MPW trades at an attractive 11.9x EV/EBITDA, well below peers, implying significant upside potential.

businesswire.com2026-03-19

Securities Fraud Investigation Into Medical Properties Trust, Inc. (MPT) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz continues its investigation of Medical Properties Trust, Inc. (“Medical Properties” or the “Company”) (NYSE: MPT) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON MEDICAL PROPERTIES TRUST, INC. (MPT), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On March 10, 2026, Medical Properti.

businesswire.com2026-03-13

Securities Fraud Investigation Into Medical Properties Trust, Inc. (MPT) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Medical Properties Trust, Inc. (“Medical Properties” or the “Company”) (NYSE: MPT) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON MEDICAL PROPERTIES TRUST, INC. (MPT), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On March 10, 2026, Medical Propertie.

defenseworld.net2026-02-13

Brokerages Set Medical Properties Trust, Inc. (NYSE:MPW) Price Target at $6.17

Shares of Medical Properties Trust, Inc. (NYSE: MPW - Get Free Report) have received an average recommendation of "Reduce" from the five research firms that are covering the firm, MarketBeat reports. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to

fool.com2026-01-30

3 Top Dividend Stocks Yielding More Than 4% to Buy Hand Over Fist This Year

All three have encountered headwinds in recent years. But they have also made progress toward addressing them.

zacks.com2026-01-28

Medical Properties (MPW) Sees a More Significant Dip Than Broader Market: Some Facts to Know

In the closing of the recent trading day, Medical Properties (MPW) stood at $5, denoting a -2.15% move from the preceding trading day.

defenseworld.net2026-01-28

Medical Properties Trust Target of Unusually High Options Trading (NYSE:MPW)

Medical Properties Trust, Inc. (NYSE: MPW - Get Free Report) was the recipient of some unusual options trading on Tuesday. Investors bought 41,204 call options on the company. This represents an increase of approximately 58% compared to the typical daily volume of 26,039 call options. Institutional Inflows and Outflows Hedge funds and other institutional investors have

seekingalpha.com2026-01-27

Medical Properties Trust: Why Short Interest Eased Substantially Before Q4 Earnings

A set of mixed catalysts have emerged recently surrounding Medical Properties Trust (MPW). On the positive side, top-line and FFO stabilization, a resumed dividend increase, and a $150M share repurchase plan support valuation recovery. On the other hand, balance sheet leverage and a recent credit downgrade to CCC+ by S&P Global remain key risks.

defenseworld.net2026-01-24

Maryland State Retirement & Pension System Decreases Position in Medical Properties Trust, Inc. $MPW

Maryland State Retirement and Pension System lessened its position in Medical Properties Trust, Inc. (NYSE: MPW) by 52.6% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 95,105 shares of the real estate investment trust's stock after selling

zacks.com2026-01-23

Investors Heavily Search Medical Properties Trust, Inc. (MPW): Here is What You Need to Know

Medical Properties (MPW) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

businesswire.com2026-01-20

Medical Properties Trust Issues Letter to Shareholders Regarding Branding Refresh

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today published a letter to shareholders from its Chairman, President, and Chief Executive Officer, Edward K. Aldag, Jr., outlining several key branding initiatives in 2026 as the Company celebrates its 20th year as a publicly traded company. As part of this update to its brand, MPT has changed its ticker symbol from “MPW” to “MPT” on the New York Stock Exchange (“NYSE”), effective at the open.

defenseworld.net2026-01-19

Medical Properties Trust, Inc. $MPW Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. decreased its position in shares of Medical Properties Trust, Inc. (NYSE: MPW) by 17.3% during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 543,029 shares of the real estate investment trust's stock after

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-03-31

"MPW reported Q1 2026 revenue of $252.1M and EPS of -$0.054. Net income was -$32.5M (net margin -12.9%). QoQ, revenue declined to $252.1M from $270.3M in Q4 2025 (-6.8%). Net income swung to a loss from +$95.9M in Q4 2025. YoY, revenue rose from $223.8M in Q1 2025 (+12.6%), but profitability deteriorated: net income moved from -$118.3M in Q1 2025 to -$32.5M in Q1 2026 (loss improved), though still negative. Across the last four quarters, the company’s reported margins remain highly volatile, with operating profitability not consistently translating into net earnings. Balance sheet-wise, liquidity improved: cash and cash equivalents increased to $425.0M (from $540.9M in Q4 2025), while total assets were $14.8B, with equity of $4.55B and net debt of -$322.5M (net cash) per the provided metrics. Debt remains small versus total capitalization in the ratios provided. On shareholder returns, marketPerformance data is unavailable (price set to 0 and 1y_change undefined), so total return cannot be reliably scored. Dividends/buybacks are not shown for Q1 2026; Q4 2025 dividends were $144.8M, suggesting ongoing shareholder payouts but without confirmation for the latest quarter."

Revenue Growth

Positive

YoY revenue up +12.6% in Q1 2026 ($252.1M vs $223.8M). QoQ revenue down -6.8% ($270.3M in Q4 2025). Growth is positive on a YoY basis but uneven sequentially.

Profitability

Caution

Net income improved YoY (loss -$32.5M vs -$118.3M), but remained negative. QoQ profitability deteriorated sharply (from +$95.9M in Q4 2025 to -$32.5M). Net margin in Q1 2026 was -12.9%, indicating margin contraction/instability.

Cash Flow Quality

Neutral

Cash flow fields for Q1 2026 are not provided (zeros), so operating cash flow and free cash flow quality cannot be confirmed for the latest quarter. Prior quarter (Q4 2025) showed negative operating cash flow (-$70.7M). Dividend paid in Q4 2025 was $144.8M, but Q1 2026 dividend data is missing.

Leverage & Balance Sheet

Positive

Total assets were $14.8B in Q1 2026 with equity of ~$4.55B. Provided ratios indicate strong balance-sheet resilience with net debt of -$322.5M (net cash) and low total-debt-to-capitalization (~2.2%).

Shareholder Returns

Caution

Total shareholder return cannot be properly assessed: marketPerformance price is 0 and 1y_change is undefined. Dividend evidence exists in Q4 2025 ($144.8M paid), but no buyback/dividend figures are provided for Q1 2026.

Analyst Sentiment & Valuation

Fair

Consensus price target data is $5 (high/low/median all 5). Without current price/1y performance from marketPerformance (price=0), valuation upside/downside and sentiment alignment cannot be quantified from the provided inputs.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

Management sounded generally confident about stabilization and cash rent ramp, citing EBITDARM momentum (coverage up to 2.6x; general acute +$130M YoY; post-acute +$50M YoY) and a stated goal of >$1B annualized cash rent by year-end 2026. The Q&A pressure points were more pointed: (1) no 1Q/2026 cash rent guidance because several “cash basis” tenants are still ramping, and only ~3% of replacement rents were not yet paying; (2) HSA collections remain below the level management wants despite ~1x full-rent coverage, with MEDITECH EMR in Q2 as a key operational lever; (3) Prospect still drove ~$34M impairment charges and leaves ~$60M of remaining bankruptcy collections expected in 2026. The Vibra restructuring alleviates a major tenant risk (new master lease; $18M cash rent collected; no impact on prior recognized revenue since it was cash-basis), but the heavy-lift is execution of rent normalization across NOR (June 2026 partial rent; Dec 2026 full) and transition tenants reaching 100% contractual rent by end-2026.

AI IconGrowth Catalysts

  • Post-acute operators EBITDARM +$50M YoY for second consecutive quarter
  • Ernest Health EBITDARM +15% YoY
  • Vibra EBITDARM +28% YoY (Q3 mentioned) driving lease restructure strength
  • Median EBITDARM +20%+ YoY with occupancy at 90% (strongest quarter since entering portfolio)
  • General acute operators EBITDARM +$130M YoY

Business Development

  • Entered a new 20-year master lease agreement with Vibra (restructuring transaction)
  • Acquired a high-performing post-acute facility in California for ~$32M (leased to Vibra per Q&A follow-up)
  • Acquired a post-acute care facility in Europe for EUR 23M
  • Sold 6 smaller underperforming properties during the quarter
  • Entered a new 15-year lease with NOR Health Systems in California (6 properties previously leased to Prospect)
  • Swiss Medical Network new clinical collaboration with Mayo Clinic (enhances long-term capabilities)
  • Ernest Health refinanced 2026 term loan and revolver in Q4, extending maturities to 2030 and compressing rate (credit enhancement)
  • LifePoint Behavioral: new leadership implementing program enhancements to modernize segment and control labor costs

AI IconFinancial Highlights

  • Normalized FFO: $0.18/share in Q4; $0.58/share for full-year 2025
  • Portfolio EBITDARM coverage increased YoY to 2.6x
  • Q4 normalized FFO benefit: ~$0.03-$0.04 higher due to cash receipts (Vibra restructuring onetime rent + $18M; HSA $4M September rent received in October)
  • Recorded impairment charges of ~$34M in Q4 (majority related to Prospect)
  • Prospect bankruptcy cash proceeds received: ~$70M in Q4; remaining ~$60M expected to be collected in 2026 as process nears end
  • Rent ramp/rent accounting: NOR partial rent begins June 2026 with ramp to 100% contractual rent by Dec 2026; MPW plans cash-basis revenue accounting for NOR

AI IconCapital Funding

  • Share repurchase plan: $150M announced last quarter; repurchased a little less than 1% of market cap through end of year
  • Debt maturities referenced: EUR 500M notes due Oct 2026 at 0.99%; bank revolver + $200M term loan maturity June 2027 (after presumed extension); $1.4B unsecured notes due Oct 2027
  • Cash collections target: expect annualized cash rent >$1B by year-end 2026 (no quarterly/annual guidance yet for 2026)
  • Investments during the quarter: ~$60M in 2 attractively priced post-acute rehabilitation facilities (to be added to master leases of long-term tenants)

AI IconStrategy & Ops

  • Facility recycling: sold 6 smaller underperforming properties; acquired 2 properties; management frames as selective—repeatable recycling with re-entry into acquisitions when opportunities arise
  • Re-tenanting/transition ramp: expect transition tenants to reach 100% contractual rent by end of 2026
  • HSA operating initiative: expected MEDITECH EMR system implementation in Q2 to support revenue cycle management enhancements and cost savings; team notes HSA expected to become fully stand-alone operationally after EMR
  • HSA collections: described as improving, but still not at desired cash level; stated to be at ~1x full rent coverage currently (coverage at 1x full rent during ramps)

AI IconMarket Outlook

  • Management reaffirmed goal of >$1B annualized cash rent by year-end 2026
  • No guidance provided on quarterly/annual cash rent collections for 1Q 2026 due to continued cash-basis accounting for several tenants and monitoring rent ramp dynamics
  • Specific 2026 rent milestone: NOR starts partial rent June 2026; 100% contractual rent by Dec 2026

AI IconRisks & Headwinds

  • Behavioral health pressure: behavioral health portfolio down slightly YoY due to volume headwinds in the U.K. market and labor cost pressures in the U.S.
  • U.K. reimbursement/funding constraints: NHS budget constraints impacting behavioral health market; Priory adjusting referral patterns and modifying service lines
  • HSA cash collections lag: described as “not where any of us would like to see them,” with ongoing ramp even as full-rent coverage ~1x
  • Prospect legacy: impairments of ~$34M (majority related to Prospect) and ongoing reliance on bankruptcy-related receivables

Sentiment: MIXED

Note: This summary was synthesized by AI from the MPW Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

📋 Official Regulatory 10-K / 10-Q SEC Filings

Direct authenticated documentation links to audited SEC database reports for MPW.

SEC EDGAR Live Feed
Loading financial data and tables...
📁

SEC Filings (MPW)

© 2026 Stock Market Info — Medical Properties Trust, Inc. (MPW) Financial Profile